Interestingly, the +42-kb enhancer that drives CEBPA expression in myeloid cells52 is active in both CIMP and AML, but absent in T-ALL (Supplementary Fig. 13a, b). The gene discussed is CEBPA; the disease is acute lymphoblastic leukemia.